Home > Share Market > Stocks > Jubilant pharmova > Financial Statements> JUBLPHARMA Profit & Loss

Jubilant Pharmova Ltd Financial Statements

Profit & Loss Statement of Jubilant Pharmova Ltd

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Revenue 6,099 9,154 7,518 5,861
yoy growth (%) (33) 21.80 28.30 1.95
Raw materials (1,536) (3,141) (2,869) (1,999)
As % of sales 25.20 34.30 38.20 34.10
Employee costs (1,923) (2,128) (1,556) (1,231)
As % of sales 31.50 23.20 20.70 21
Other costs (1,243) (1,939) (1,575) (1,286)
As % of sales 20.40 21.20 20.90 21.90
Operating profit 1,396 1,947 1,518 1,345
OPM 22.90 21.30 20.20 23
Depreciation (349) (462) (415) (291)
Interest expense (184) (287) (284) (341)
Other income 17.60 47.40 40 24.90
Profit before tax 881 1,245 859 738
Taxes (297) (312) (225) (163)
Tax rate (34) (25) (26) (22)
Minorities and other 262 -- 8.39 1.03
Adj. profit 846 933 643 576
Exceptional items (21) (35) -- --
Net profit 836 898 643 576
yoy growth (%) (6.90) 39.70 11.70 46.90
NPM 13.70 9.81 8.55 9.82

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000